| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2264513C Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 03/30/2004 | CA2079706C Inhibitor of atherosclerotic intimal thickening |
| 03/25/2004 | WO2004024723A1 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 03/25/2004 | WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 03/25/2004 | WO2004024718A1 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors |
| 03/25/2004 | WO2004024717A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 03/25/2004 | WO2004024707A2 Process for preparing amine type substituted benzofurans |
| 03/25/2004 | WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 03/25/2004 | WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors |
| 03/25/2004 | WO2004024697A1 Amine compounds and use thereof |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024691A1 Cox-2 inhibiting pyridine derivatives |
| 03/25/2004 | WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites |
| 03/25/2004 | WO2004024159A1 INHIBITORS OF TFGβ |
| 03/25/2004 | WO2004024148A1 Nr3b1 nuclear receptor binding 3-substituted pyrazoles |
| 03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
| 03/25/2004 | WO2004024060A2 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003051846A3 Substituted phenyl derivatives |
| 03/25/2004 | WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 03/25/2004 | WO2003022838A8 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040059138 Dihydropyrancarboxamides and uses thereof |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059127 Process and intermediates for the preparation of imidazopyridines |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/25/2004 | US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058853 Multivalent neuraminidase inhibitor conjugates |
| 03/25/2004 | DE10243234A1 New tocopheryl esters of aminoacids or derivatives, useful in cosmetic or dermatological compositions, e.g. for protecting skin against osmotic and oxidative stress and/or treating inflammation |
| 03/25/2004 | CA2502583A1 Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same |
| 03/25/2004 | CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | CA2498460A1 Inhibitors of tfg.beta. |
| 03/25/2004 | CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 03/25/2004 | CA2498010A1 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 03/25/2004 | CA2493497A1 Cox-2 inhibiting pyridine derivatives |
| 03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1400241A1 Fused cyclic compounds and medicinal use thereof |
| 03/24/2004 | EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399438A1 Novel heteroaryl derivatives, their preparation and use |
| 03/24/2004 | EP1399437A1 Method for the production of triazolylmethylepoxides |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 03/24/2004 | EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production |
| 03/24/2004 | EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 03/24/2004 | EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 03/24/2004 | EP1399156A2 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity |
| 03/24/2004 | EP1280796B1 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 03/24/2004 | EP1186601B1 Novel isoquinoline derivatives or salts thereof |
| 03/24/2004 | EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes |
| 03/24/2004 | EP0922036B1 Arylalkanoyl pyridazines |
| 03/24/2004 | EP0912543B1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/24/2004 | CN1142931C 4-tetrahydropyridylpyrimidine derivatives |
| 03/24/2004 | CN1142927C Chalcone coumarins |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142919C Quinazoline derivatives as antitumor agents |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/24/2004 | CN1142916C Dopamine D1 receptor agonist compounds |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6711394 RF receiver having cascaded filters and an intermediate amplifier stage |
| 03/23/2004 | US6710078 Antitumor, anticancer agents |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710047 Phthalazines with angiogenesis inhibiting activity |
| 03/23/2004 | US6710044 Technical field |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 03/18/2004 | WO2004022539A1 Naphthyl ether compounds and their use |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003087094A3 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 03/18/2004 | WO2003086563A3 Diabetes imaging probes |
| 03/18/2004 | WO2003079975A3 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |
| 03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |